|
Delayed
Hong Kong S.E.
11:51:08 27/08/2026 HKT
|
5-day change | 1st Jan Change | ||
| 9.620 HKD | +1.00% |
|
+1.05% | +14.12% |
| 08-26 | CSPC Pharma's Colorectal Cancer Drug Candidate Gets Fast Track Designation by US FDA | MT |
| 08-26 | CSPC Pharma's Lung Cancer Candidate Meets Progression-Free Survival Primary Endpoint | MT |
| Market Cap | 109B 13.89B 11.92B 11.19B 10.22B 19.29B 1,325B 19.38B 132B 51.33B 668B 52.16B 51.03B 2,214B | P/E 2026 * |
10.8x | P/E 2027 * | 16x |
|---|---|---|---|---|---|
| Enterprise Value | 98.08B 12.51B 10.74B 10.08B 9.21B 17.37B 1,193B 17.46B 119B 46.23B 602B 46.98B 45.96B 1,994B | EV / Sales 2026 * |
2.54x | EV / Sales 2027 * | 2.66x |
| Free-Float |
67.42% | Yield 2026 * |
4.74% | Yield 2027 * | 3.8% |
| 1 day | -0.58% | ||
| 1 week | -0.53% | ||
| Current month | +10.37% | ||
| 1 month | +14.10% | ||
| 3 months | +34.52% | ||
| 6 months | -4.34% | ||
| Current year | +12.34% |
| 1 week | 9.02 |  | 9.98 |
| 1 month | 8.21 | | 10.17 |
| Current year | 6.53 | | 10.96 |
| 1 year | 6.53 | | 11.63 |
| 3 years | 4.27 | | 11.63 |
| 5 years | 4.27 | | 11.63 |
| 10 years | 3.87 | | 13.93 |
| Manager | Title | Age | Since |
|---|---|---|---|
Lei Cai
CEO | Chief Executive Officer | 46 | 19/12/2025 |
Qing Jie Wei
COO | Chief Operating Officer | 56 | 19/12/2025 |
Zhi Yong Qu
PRN | Corporate Officer/Principal | 44 | 01/07/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Dong Chen Cai
CHM | Chairman | 72 | 26/08/2011 |
Zhen Guo Wang
BRD | Director/Board Member | 56 | 20/01/2012 |
Bo Wang
BRD | Director/Board Member | 66 | 21/12/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 23/6/26 | Other | Director | -700,000 | 0.0061% | ||
| 23/12/25 | Other | Chairman | 6,706,000 | 0.0582% | ||
| 25/11/25 | Other | Chairman | 10,300,000 | 0.0894% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.31% | -0.53% | -2.57% | +60.51% | 13.73B | |
| -3.59% | -7.10% | +61.60% | +114.83% | 1,100B | |
| -1.15% | -1.25% | +52.98% | +62.41% | 658B | |
| -1.09% | -1.15% | +26.18% | +79.22% | 470B | |
| -1.47% | +0.24% | +42.09% | +42.09% | 372B | |
| -0.90% | +0.05% | +25.57% | +41.75% | 304B | |
| -1.94% | +1.53% | +3.05% | +13.24% | 264B | |
| -0.43% | -0.46% | +52.06% | +71.75% | 239B | |
| -0.93% | +1.84% | -13.11% | -52.28% | 213B | |
| -0.46% | +0.33% | +29.05% | +92.67% | 184B | |
| Average | -1.25% | +0.85% | +27.69% | +52.62% | 381.66B | |
| Weighted average by Cap. | -1.82% | -1.55% | +40.38% | +68.21% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 38.62B 4.93B 4.23B 3.97B 3.63B 6.84B 470B 6.87B 46.97B 18.2B 237B 18.5B 18.1B 785B | 35.63B 4.55B 3.9B 3.66B 3.34B 6.31B 434B 6.34B 43.33B 16.79B 219B 17.07B 16.7B 724B |
| Net income | 10.12B 1.29B 1.11B 1.04B 950M 1.79B 123B 1.8B 12.31B 4.77B 62.13B 4.85B 4.74B 206B | 6.98B 891M 764M 718M 655M 1.24B 84.95B 1.24B 8.49B 3.29B 42.86B 3.34B 3.27B 142B |
| Net Debt | -10.82B -1.38B -1.18B -1.11B -1.02B -1.92B -132B -1.93B -13.15B -5.1B -66.39B -5.18B -5.07B -220B | -14.06B -1.79B -1.54B -1.44B -1.32B -2.49B -171B -2.5B -17.1B -6.63B -86.3B -6.73B -6.59B -286B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 27/08/26 | HK$9.620 | +1.00% | 44,915,216 |
| 26/08/26 | HK$9.525 | +1.22% | 190,279,844 |
| 25/08/26 | HK$9.410 | +0.16% | 126,608,259 |
| 24/08/26 | HK$9.395 | +2.23% | 141,570,805 |
| 21/08/26 | HK$9.190 | -3.47% | 135,368,018 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 1093 Stock
Select your edition
All financial news and data tailored to specific country editions
